Skip to main content

Covaxin is effective against UK variant of coronavirus: ICMR study


Covaxin is effective against the new variant of COVID-19 that was traced in the UK, an ICMR study has said. "Covaxin, developed by Bharat Biotech with ICMR, has equivalent immunogenicity against the UK-variant and %3D circulating strains of SARS-COV-2 in India," tweeted ICMR. "It's reassuring the vaccine can work against the new UK variant," said ICMR Director General Dr Balram Bhargava. Continue...  

Comments

  1. I just loved the way to discover the unknown or partially known things of our planet !! Just loved it!! Keep it up!! #adventure 🤘

    ReplyDelete

Post a Comment

Popular posts from this blog

New species of 'orange and black' bat discovered in West Africa

 A new species of orange and black bat from the Nimba Mountains in West Africa has been discovered by scientists from the American Museum of Natural History and Bat Conservation International. The species has been named Myotis nimbaensis in recognition of the Guinea mountain range it inhabits. "It has this bright-orange fur.it was so distinct," said scientist Winifred Frick. Continue...

Frontier of Dreams: Revolutionizing Healthcare: AI and the Future of Patient Care

Frontier of Dreams: Revolutionizing Healthcare: AI and the Future of Patient Care Chapter 1: The Pulse of Progress – Why AI Matters in Healthcare Introduction: A New Era Dawns Healthcare is standing at the threshold of a revolutionary transformation. Artificial intelligence (AI) is not merely a technological upgrade; it is a paradigm shift that redefines how we approach diagnosis, treatment, and patient engagement. This chapter lays the foundation for understanding AI's relevance, power, and promise in today’s healthcare landscape. Main Points 1. The Data-Driven Shift: The digital revolution has flooded healthcare with vast amounts of data. AI transforms this raw information into actionable intelligence, helping clinicians make faster and more accurate decisions. 2. Limitations of Traditional Models: Human limitations such as fatigue, oversight, and processing constraints hinder healthcare delivery. AI's computational power overcomes these boundaries, offering consistent pe...

NASA develops COVID-19 prototype ventilator in 37 days

NASA has developed VITAL (Ventilator Intervention Technology Accessible Locally), a high-pressure ventilator in 37 days to treat COVID-19 patients. The device is composed of far fewer parts, many of which are available to potential manufacturers, NASA said. "Its flexible design means it can be modified for use in hospitals being set up in hotels and other high- capacity facilities," NASA added.